Lee Eui-kyung

Q: What Schools Are Affiliated With Lee Eui-kyung

Lee Eui-kyung is affiliated with the following schools: Pusan National University, Sungkyunkwan University, University of Iowa, Yonsei University, Sookmyung Women's University, Seoul National University

Lee Eui-kyung's AcademicInfluence.com Rankings

Lee Eui-kyung

Medical

#1313

World Rank

#1639

Historical Rank

Pharmacology

#479

World Rank

#537

Historical Rank

medical Degrees

Download Badge

Medical

Lee Eui-kyung's Degrees

Bachelors Pharmacy Seoul National University
Masters Pharmacology Yonsei University

Why Is Lee Eui-kyung Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Lee Eui-kyung is a South Korean professor of pharmacy at Sungkyunkwan University who has previously served as President Moon Jae-in's Minister of Food and Drug Safety from 2019 to 2020. Education Lee holds three degrees in pharmacy: Bachelor and Master's from Seoul National University and Ph.D. from University of Iowa.

(See a Problem?)

Lee Eui-kyung's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database (2013) (67)
Magnetic Resonance Imaging Is Cost‐Effective for Hepatocellular Carcinoma Surveillance in High‐Risk Patients With Cirrhosis (2019) (60)
Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea (2018) (52)
Pharmacoeconomic guidelines and their implementation in the positive list system in South Korea. (2009) (41)
Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach (2014) (37)
Food away from home and body mass outcomes: taking heterogeneity into account enhances quality of results. (2014) (29)
Eliciting public preference for health-care resource allocation in South Korea. (2012) (28)
Health Care Utilization and Direct Costs in Mild, Moderate, and Severe Adult Asthma: A Descriptive Study Using the 2014 South Korean Health Insurance Database. (2017) (24)
Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study (2015) (24)
Gender Differences in the Impact of Obesity on Health-Related Quality of Life (2016) (22)
Effects of computerized physician order entry on medication turnaround time and orders requiring pharmacist intervention. (2014) (22)
Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data (2016) (21)
Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B (2020) (21)
Evaluation of the pilot program on the real-time drug utilization review system in South Korea (2013) (20)
A comparison of preferences of targeted therapy for metastatic renal cell carcinoma between the patient group and health care professional group in South Korea. (2012) (20)
Out-of-pocket Medication Expenditure Burden of Elderly Koreans with Chronic Conditions (2015) (20)
Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea. (2012) (20)
The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population (2014) (19)
Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea (2016) (19)
Cost-Utility Analysis of Sacubitril/Valsartan Use Compared With Standard Care in Chronic Heart Failure Patients With Reduced Ejection Fraction in South Korea. (2019) (19)
Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes (2017) (19)
Comparison of peptic-ulcer drug use and expenditures before and after the implementation of a government policy to separate prescribing and dispensing practices in South Korea. (2003) (18)
Evaluation of cost-utility of varenicline compared with existing smoking cessation therapies in South Korea. (2009) (18)
Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea. (2015) (17)
Effects of nutrition support team services on outcomes in ICU patients. (2011) (17)
Evaluation of willingness to pay per quality-adjusted life year for a cure (2018) (17)
Evaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea (2017) (16)
Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea (2017) (15)
Perception of reporting medication errors including near-misses among Korean hospital pharmacists (2017) (15)
The effect of the introduction of a nationwide DUR system where local DUR systems are operating - The Korean experience (2015) (14)
Socioeconomic and Employment Status of Patients with Rheumatoid Arthritis in Korea (2012) (14)
Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study (2018) (14)
Persistence of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: An analysis of the South Korean National Health Insurance Database. (2018) (13)
Living arrangements, chronic diseases, and prescription drug expenditures among Korean elderly: vulnerability to potential medication underuse (2014) (12)
Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia (2019) (12)
Pharmacogenomic Biomarker Information in FDA‐approved Paediatric Drug Labels (2015) (12)
Comparison of benefit–risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experiments (2016) (11)
Estimation of cost savings between 2011 and 2014 attributed to infliximab biosimilar in the South Korean healthcare market: real‐world evidence using a nationwide database (2018) (11)
Effect of sex and age on the association between suicidal behaviour and obesity in Korean adults: a cross-sectional nationwide study (2016) (11)
Cost-effectiveness of tiotropium in elderly patients with severe asthma using real-world data. (2020) (11)
Healthcare Costs for Acute Hospitalized and Chronic Heart Failure in South Korea: A Multi-Center Retrospective Cohort Study (2017) (11)
A comparative analysis of the impact of a positive list system on new chemical entity drugs and incrementally modified drugs in South Korea. (2011) (11)
Factors influencing the difference between forecasted and actual drug sales volumes under the price-volume agreement in South Korea. (2016) (11)
Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis. (2015) (10)
National reimbursement listing determinants of new cancer drugs: a retrospective analysis of 58 cancer treatment appraisals in 2007–2016 in South Korea (2017) (10)
Single-Tooth Implant Versus Three-Unit Fixed Partial Denture: A Study of Oral Health-Related Quality of Life. (2016) (10)
Medical costs for Korean patients with rheumatoid arthritis based on the national claims database (2012) (10)
Signal detection of benzodiazepine use and risk of dementia: sequence symmetry analysis using South Korean national healthcare database (2018) (10)
Gastrointestinal risk of non-steroidal anti-inflammatory drugs and gastroprotective agents used in the treatment of osteoarthritis in elderly patients: A nationwide retrospective cohort study . (2019) (9)
A comparison of discontinuation rates of tofacitinib and biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis: a systematic review and Bayesian network meta-analysis. (2017) (9)
Cost-effectiveness Analysis of Treatment Sequence Initiating With Etanercept Compared With Leflunomide in Rheumatoid Arthritis: Impact of Reduced Etanercept Cost With Patent Expiration in South Korea. (2016) (9)
Use pattern and predictors of use of highly caffeinated energy drinks among South Korean adolescents: a study using the Health Belief Model (2017) (9)
Assessment of the Price-Volume Agreement Program in South Korea. (2016) (9)
Development of a transformation model to derive general population–based utility: Mapping the pruritus–visual analog scale (VAS) to the EQ‐5D utility (2017) (9)
Cost-effectiveness of tolvaptan for euvolemic or hypervolemic hyponatremia. (2014) (8)
Higher prevalence of dementia in patients with schizophrenia: A nationwide population‐based study (2016) (8)
A Comparison of Leukotriene Receptor Antagonists to Low-Dose Inhaled Corticosteroids in the Elderly with Mild Asthma. (2019) (7)
Lifetime effectiveness of mifamurtide addition to chemotherapy in nonmetastatic and metastatic osteosarcoma: a Markov process model analysis (2015) (7)
Prevalence and predictors of tricyclic antidepressant use among elderly Koreans in primary-care and specialty clinics. (2018) (7)
Prevalence and predictors of hypoglycemia in South Korea. (2018) (7)
Differences in the risk of mood disorders in patients with asthma-COPD overlap and in patients with COPD alone: a nationwide population-based retrospective cohort study in Korea (2019) (6)
Does Early Retrograde Intrarenal Surgery Improve the Cost-Effectiveness of Renal Stone Management? (2020) (6)
The addition of mifamurtide to chemotherapy improves lifetime effectiveness in children with osteosarcoma: a Markov model analysis (2014) (6)
Comparison of Effectiveness Between Delamanid and Bedaquiline Among Patients with Multidrug-Resistant Tuberculosis: A Markov Model Simulation Study (2016) (6)
The Utility of 5 Hypothetical Health States in Heart Failure Using Time Trade-Off (TTO) and EQ-5D-5L in Korea (2018) (5)
Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea (2018) (5)
Current status of pharmacovigilance regulatory structures, processes, and outcomes in the Asia‐Pacific region: Survey results from 15 countries (2019) (5)
Effect of the Clinic-based Chronic Disease Management Program on the Appropriateness of Medication Adherence and Persistence in Hypertension Patients in Korea (2017) (4)
Visual Outcomes and Optical Quality of Accommodative, Multifocal, Extended Depth-of-Focus, and Monofocal Intraocular Lenses in Presbyopia-Correcting Cataract Surgery: A Systematic Review and Bayesian Network Meta-analysis. (2022) (4)
Pattern of Asthma Management by Primary Physicians in Seoul. (2003) (4)
Sociodemographic factors influencing the use of injections in South Korean outpatient care (2014) (4)
Analysis of Medical Use and Costs Related to the Management of Liver Cirrhosis Using National Patients Sample Data (2016) (4)
Generic Utilization in the Korean National Health Insurance Market; Cost, Volume and Influencing Factors (2014) (4)
Different policy outcomes of the new drugs and currently listed drugs under the positive list system in South Korea. (2012) (4)
Haematological cancer versus solid tumour end-of-life care: a longitudinal data analysis (2020) (3)
A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments (2021) (3)
Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants (2021) (3)
Comparison of first- and second-generation antihistamine prescribing in elderly outpatients: A health insurance database study in 2013. (2017) (3)
Analysis of Factors Affecting Medication Compliance of Outpatients (2002) (3)
Stakeholder Analysis for Adopting a Personal Health Record Standard in Korea (2015) (3)
Analysis of Prescriptions for Oral Solid Dosage Forms Split at Primary Health Care Using National Health Insurance Database (2007) (3)
Impact of the Purchasing Price Reimbursement System for Insurance Drugs upon the Health Insurer`s Financial Situation (2005) (2)
Analysis of Perception on the Bioequivalence-assured Generic Drugs (2006) (2)
PCV112 EXTENSION OF META-ANALYSIS IN COMPARING OF FIMASARTAN WITH LOSARTAN IN BLOOD PRESSURE LOWERING EFFECT (2011) (2)
Cost-Minimization Analysis of Biologic Disease-Modifying Antirheumatic Drugs Administered by Subcutaneous Injections in Patients with Rheumatoid Arthritis (2016) (2)
Cost-Benefit Analysis of Clinical Pharmacokinetic Consultation Service of Theophylline (2000) (2)
A benefit–risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients (2016) (2)
Pharmacoeconomic Evaluation of Antimuscarinic Agents for the Treatment of Overactive Bladder- With Solifenacin and Tolterodine IR - (2008) (2)
Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation (2022) (2)
Healthcare utilization and medical expenditure of Korean psoriasis patients (2018) (2)
Therapeutic efficacy of new botulinum toxin identified in CCUG 7968 strain (2021) (2)
Healthcare resource utilization and medical costs in patients with terminal cancer during best supportive care (2022) (2)
Prescribing Pattern and Safety Analysis of Nonsteroidal Anti-inflammatory Drug and Gastro- Protective Agent following Reimbursement Guidelines Relaxation (2017) (2)
Cost-Effectiveness of Adjuvant Immunotherapy With Cytokine-Induced Killer Cell for Hepatocellular Carcinoma Based on a Randomized Controlled Trial and Real-World Data (2021) (2)
Economic burden of brain metastases in non-small cell lung cancer patients in South Korea: A retrospective cohort study using nationwide claims data (2022) (1)
Quantitative Benefit–Risk Assessment of COVID-19 Vaccines Using the Multi-Criteria Decision Analysis (2022) (1)
Analysis of the Hospital Pharmacists Turnover after the Separation of Prescribing and Dispensing Practice (2002) (1)
Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study-authors' response. (2019) (1)
Pharmacokinetics of a telmisartan, amlodipine and hydrochlorothiazide fixed-dose combination: A replicate crossover study in healthy Korean male subjects (2017) (1)
Meta-analysis of Inline Filtration Effects on Post-infusion Phlebitis Caused by Particulate Contamination of Intravenous Administration (2010) (1)
Analysis of Media Reports on the Safety of Herbal Medicines from the Viewpoint of Risk Communication (2014) (1)
Importance of a usual source of care in choosing low-priced generic drugs: a cross-sectional study. (2022) (1)
Incremental impact of body mass status with modifiable unhealthy lifestyle behaviors on pharmaceutical expenditure. (2016) (1)
Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis (2022) (1)
Analysis of Economic Outcomes of Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia Using Retrospective Case-control Study (2007) (1)
Evaluation of Good Clinical Practice(GCP) Implementability at the Designated Clinical Trial Hospitals (1995) (1)
Measuring the Seriousness of Adverse Drug Reactions : Comparisons between Korean Experts and WHO Working Group Members (2011) (1)
Factors Associated With the Management of Adverse Drug Reactions Among Community Pharmacists in South Korea. (2015) (1)
Estimating the Price Elasticity of Demand for Off-Patent Prescription Drugs (2017) (1)
REVISIT THE EFFECT OF THE PRENATAL MEDICAL CARE USE ON THE BIRTH OUTCOME OF NEWBORN BABY (2015) (1)
Effects of Pioglitazone and Rosiglitazone on Glucose and the Cardiovascular Risk Factors in Patients with Type 2 Diabetes: A Meta-analysis (2009) (1)
Proton‐pump inhibitors and the risk of Clostridium difficile–associated diarrhea in high‐risk antibiotics users: A population‐based case‐crossover study (2019) (1)
Use of injectable drugs with oral-formulation alternatives for outpatients in South Korea (2015) (1)
PRS37 THE PRICE NEGOTIATION ON PHARMACEUTICALS AFTER THE INTRODUCTION OF POSITIVE LIST SYSTEM IN SOUTH KOREA (2011) (0)
A Case Study using Transferability Diagnosis Tools BetweenCountries for Economic Evaluations of Rheumatoid Arthritis Drugs (2009) (0)
Comparative Effectiveness of Biologic DMARDs in Rheumatoid Arthritis Patients with Inadequate Response to conventional DMARDs: Using a Bayesian Network Meta-analysis (2015) (0)
A Relationship Between Body Mass Index and Health-Related Quality of Life Among Koreans with Diabetes: The Korea National Health and Nutrition Examination Survey (2013) (0)
Use of injectable drugs with oral-formulation alternatives for outpatients in South Korea (2014) (0)
Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data (2021) (0)
PCN83 A COMPARISON OF PREFERENCES FOR TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA (2011) (0)
Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012 (2018) (0)
PHP65 Factors Influencing Reimbursement Price of New Drugs After Introduction of Positive List System (2012) (0)
PIN72 Cost-Effectiveness Analysis of Palivizumab With Risk Factors for Respiratory Syncytial Virus Prevention (2012) (0)
Evaluating Willingness-To-Pay Threshold for Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Contingent Valuation Survey (2013) (0)
Pharmacoeconomic Analysis of Tafluprost compared with Latanoprost on the Treatment of Primary open Angle Glaucoma or Ocular Hypertension in Korea (2010) (0)
Decreasing Acef Score In Patients Underwent Myocardial Infarction Affects Patients’ Life Years Gained (2017) (0)
Health-related quality of life in adult patients with asthma according to asthma control and severity: A systematic review and meta-analysis (2022) (0)
Economic Burden of Recurrence in Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer: A Retrospective Study Using Nationwide Claims Data of South Korea (2022) (0)
Cost-effectiveness of Combination Therapy of Anticoagulants/antiplatelets with Proton Pump Inhibitors: A Systematic Review (2022) (0)
Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System (2022) (0)
PHP49 The Pharmacist'S Perception of the Splitting Extended Release and Enteric-Coated Formulation Drugs (2011) (0)
Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis (2023) (0)
Cost-effectiveness analysis of smoking cessation interventions with behavioral support: a study based on the Benefits of Smoking Cessation on Outcomes (BENESCO) model. (2022) (0)
Development and Validation of a Trigger Tool for Identifying Drug-Related Emergency Department Visits (2021) (0)
Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach (2014) (0)
The Effect of Policies for Improving the Access to New Medicines in South Korea: A Retrospective Analysis in 2007 - 2016 (2017) (0)
PCN74 Cost-Effectiveness Analysis of Chemoprevention for Colorectal Cancer by Low Dose Aspirin in South Korea (2011) (0)
Comparison of Chronic Myeloid Leukemia Patient's Utility Weights (2009) (0)
PHS48 Cost-Effectiveness Analysis of Tolvaptan for Hyponatreamia in South Korea (2012) (0)
Cost implications of adverse drug event-related emergency department visits – a multicenter study in South Korea (2020) (0)
Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea. (2017) (0)
PIH26 MEDICATION COMPLIANCE AND ITS AFFECTING FACTORS IN CLINICAL TRIALS IN SOUTH KOREA (2011) (0)
Policy Directions to Improve Consumer Welfare by Comparative Analysis of Drug Distribution- Focused on the Survey Analysis of Direct vs Wholesale Distribution - (2008) (0)
Patient Access to Cancer Care Excellence (Pace) South Korea Survey (2015) (0)
Comparative Analysis of the Seriousness of the Adverse Eventsand Risk of Targeted Therapy for Metastatic Renal CellCarcinoma Among Medical Professionals (2011) (0)
PMS16 COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASE (2011) (0)
Quantile regression analyses on associated factors for obesity among adolescents in Korea (2015) (0)
PCN83 Cost-Effectiveness Analysis of Combination Therapies Including Class II Anticancer Drug for Advanced or Metastatic Gastric Cancer (2011) (0)
Heterogeneity in the association of food away from home consumption with body weight outcomes: evidence from South Korea (2014) (0)
Eliciting the Relative Importance of Key Elements for Benefit-Risk Assessment: A Comparison Among General Population, Health Authority and Medical Doctors (2013) (0)
Clinical impact and economic burden of post-transplant infections following heart transplantation: A retrospective nationwide cohort study. (2022) (0)
Understanding patient and physician responses to various cost-sharing programs for prescription drugs in South Korea: A multilevel analysis (2022) (0)
FRI-182-Anti-viral treatment in patients with immune tolerant-phase chronic hepatitis B may be cost-effective (2019) (0)
Estimation of Willingness to Pay for a Quality-Adjusted Life Year on a Cure (2016) (0)
Estimation of Health Utilities Based on the Response to Treatment in Atopic Dermatitis: a Population-based Study. (2019) (0)
Impact and Barriers of the Health Insurance Review on Splitting Extended-Release Formulation Drugs (2011) (0)
PMU19 Access to Medication Information By Hospitalized Patients from Bedside Terminal (2020) (0)
Comparison of Literature Retrieval Engines for Pharmacoeconomic Evaluation Research of Bupropione or Varenicline Therapy for Smoking Cessation (2007) (0)
PHP149 Perception of Pharmaceutical Companies on the Drug Price-Volume Negotiation in South Korea (2011) (0)
Health-Related Quality Of Life Of Patients With Rheumatoid Arthritis In Korea: The Korea National Health And Nutrition Examination Survey (2014) (0)
FRI0374 THE RISK OF INFECTION BY TUMOR NECROSIS FACTOR INHIBITORS AND ITS ASSOCIATED FACTORS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULT FROM KOREAN NATIONAL HEALTH INSURANCE DATA (2019) (0)
PSS24 COST EFFECTIVENESS ANALYSIS OF TAFLUPROST COMPARED WITH LATANOPROST ON THE TREATMENT OF PRIMARY OPEN ANGLE GLAUCOMA IN SOUTH KOREA (2009) (0)
Value-Based Pricing and Budget Impact Analysis for Multi-Indication Drugs: A Case Study of Immunotherapies (2022) (0)
Comparative Analysis of Ethical-the-counter Drugs and Over-the-counter Drugs for the Adverse Events from the Community Pharmacy (2018) (0)
Open Innovation Modes and Characteristics of the Domestic Pharmaceutical Companies in Korea (2016) (0)
Estimation Of Change In Prescription Drug Expenditures On The Reference Pricing System In South Korea (2014) (0)
Cost-effectiveness of Early Use of Etanercept in the Treatment of Rheumatoid Arthritis (2009) (0)
A Meta-Analysis of Utility Weights for Stroke (2009) (0)
Regulatory effect of decreasing therapeutic duplication of respiratory drugs using a prescription database between 2012 and 2015 (2019) (0)

This paper list is powered by the following services:

Other Resources About Lee Eui-kyung

en.wikipedia.org

What Schools Are Affiliated With Lee Eui-kyung?

Lee Eui-kyung is affiliated with the following schools:

Lee Eui-kyung's Academic­Influence.com Rankings